Pharma News

BioNTech SE a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, and Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs towards commercialization, pending regulatory authorizations. In connection with the strategic collaboration, the companies entered into a license and option agreement and a securities purchase agreement.

Bristol Myers Squibb announced two regulatory acceptances for applications for neoadjuvant Opdivo (nivolumab) with chemotherapy followed by surgery and adjuvant Opdivo for the perioperative treatment of resectable stage IIA to IIIB non-small cell lung cancer (NSCLC). The U.S. Food and Drug Administration (FDA) accepted the supplemental Biologics Application (sBLA) and assigned a Prescription Drug User Fee Act (PDUFA) goal date of October 8, 2024.

Low blood sugar levels (hypoglycemia) are one of the most dangerous complications of diabetes and pose high risk during cognitively demanding tasks requiring complex motor skills, such as driving a car. The utility of current tools to detect hypoglycemia is limited by diagnostic delay, invasiveness, low availability, and high costs. A recent study published in the journal NEJM AI provides a novel way to detect hypoglycemia during driving.

A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.

Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.

Many neurodegenerative diseases, including Alzheimer’s and Parkinson’s, are difficult to diagnose before symptoms begin to appear. However, disease-related biomarkers such as aggregated proteins called amyloids could provide important insight much earlier, if they can be readily detected. Researchers publishing in ACS Sensors have developed one such method using an array of sensor molecules that can light up amyloids. The tool could help monitor disease progression or distinguish between different amyloid-related conditions.

Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others do not. A study from the University of Gothenburg describes this newly discovered mechanism.

The 7th Annual Pharma Project and Portfolio Management 2024, held at Fairfield By Marriott in South Goa from January 17th to 19th, 2024, marked a significant milestone as of the best EBM event to date. Addressing challenging R&D project issues, the conference offered a comprehensive program to tackle industry pain points and enhance understanding of intellectual property (IP) and portfolio dynamics within the global pharma sector.

Aiming for Viksit Bharat by 2047 and with a sharp focus and providing momentum to Nari Shakti, Union Minister for Finance & Corporate Affairs, Smt. Nirmala Sitharaman today proposed vaccination to prevent Cervical Cancer and amalgamation of various schemes for maternal and child care, as she presented the Interim Budget 2024-25 in Parliament today.